Operating Segments

12 Months Ended

Dec. 31, 2020

Segment Reporting [Abstract]

Operating Segments

Note 13. Operating Segments

The Company maintains two active operating segments: Specialized BioTherapeutics and Public Health Solutions. Each segment includes an element of overhead costs specifically associated with its operations, with its corporate shared services group responsible for support functions generic to both operating segments.

	For the Years Ended December 31,
	2020			2019
Revenues
Public Health Solutions	$	2,242,078		$	3,402,014
Specialized BioTherapeutics		117,369			1,227,902
Total	$	2,359,447		$	4,629,916
Income (Loss) from Operations
Public Health Solutions	$	(435,028	)	$	153,969
Specialized BioTherapeutics		(13,610,715	)		(6,738,284	)
Corporate		(4,540,764	)		(3,956,706	)
Total	$	(18,586,507	)	$	(10,541,021	)
Amortization and Depreciation Expense
Public Health Solutions	$	21,672		$	17,507
Specialized BioTherapeutics		11,839			18,122
Corporate		28,861			18,821
Total	$	62,372		$	54,450
Other Income (Expense), Net
Specialized BioTherapeutics	$	71,974			425,785
Corporate		(10,882	)		148,968
Total	$	61,092		$	574,753
Share-Based Compensation
Public Health Solutions	$	47,453		$	36,003
Specialized BioTherapeutics		148,107			107,214
Corporate		214,373			233,122
Total	$	409,933		$	376,339

	As of December 31,
	2020		2019
Identifiable Assets
Public Health Solutions	$	176,447	$	1,018,673
Specialized BioTherapeutics		147,784		41,705
Corporate		19,567,004		6,714,983
Total	$	19,891,235	$	7,775,360